Position in STVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,235,319
+$50,523 QoQ
Shares Held
68,363
-20.7% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#51
of 124 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in STVN Over Time
Shares Held
Position Value (USD)
Position in Medical Instruments & Supplies
Healthcare · as of Jun 30, 2026PALISADE CAPITAL MANAGEMENT, LP holds $55,505,739 across 7 Medical Instruments & Supplies names. STVN ranks #7 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RGEN |
Repligen Corp
|
109,768 | $14,976,745 | |
| 2 | NVST |
Envista Holdings Corp
|
534,175 | $14,075,511 | |
| 3 | BLFS |
Biolife Solutions Inc
|
352,737 | $9,961,292 | |
| 4 | AZTA |
Azenta, Inc.
|
295,898 | $7,551,316 | |
| 5 | WRBY |
Warby Parker Inc.
|
181,086 | $5,494,149 | |
| 6 | ATR |
Aptargroup, Inc.
|
17,663 | $2,211,407 | |
| 7 | STVN |
Stevanato Group S.p.A.
This page
|
68,363 | $1,235,319 |
All Filings in STVN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,235,319 | 68,363 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,184,796 | 86,167 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,133,343 | 106,031 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,916,161 | 113,249 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,362,478 | 96,704 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,867,021 | 91,431 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $1,310,624 | 60,148 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,194,280 | 59,714 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||